Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model

Current treatments for demyelinating diseases are generally only capable of ameliorating the symptoms, with little to no effect in decreasing myelin loss nor promoting functional recovery. Mesenchymal stem cells (MSCs) have been shown by many researchers to be a potential therapeutic tool in treatin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Cruz-Martinez, P, González-Granero, S, Molina-Navarro, M M, Pacheco-Torres, J, García-Verdugo, J M, Geijo-Barrientos, E, Jones, J, Martinez, S
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4917663/
https://ncbi.nlm.nih.gov/pubmed/27171265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2016.130
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados